4-7-8 Breathing for Fatigue and Sleep Management in Hemodialysis
Not yet recruitingNot applicableNCT07700693
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
For many hemodialysis patients, fatigue and sleep disturbances are common and debilitating side effects that severely impact daily life and quality of life. In this study, patients will be taught a simple breathing exercise called the 4-7-8 technique to help manage these symptoms. A total of 80 adult patients undergoing regular hemodialysis at Izmir Atatürk Training and Research Hospital will be randomly assigned to two groups: an intervention group and a control group. Participants in the intervention group will receive a face-to-face training session from a research nurse and a short instructional video sent to their smartphones to encourage daily home practice, especially before bedtime. The program will be continued over the study period. Participants in the control group will continue with their current routine hemodialysis care without any structured breathing exercises. Fatigue levels, sleep quality, and daytime sleepiness will be measured in both groups before and after the program using validated questionnaires. The results of this study may provide nurses and patients with a safe, cost-effective, non-drug option to improve symptom management and overall well-being in hemodialysis patients.
Study details
- Official title
- The Effect of the 4-7-8 Breathing Exercise Program on the Management of Fatigue and Sleep Disorders in Hemodialysis Patients: A Randomized Controlled Trial
- Conditions
- Chronic Kidney Diseases
- Insomnia
- 4-7-8 Breathing Technique
- Interventions
- Behavioral: Breathing technique
- Sponsor
- Izmir Kavram Vocational School
- Start date
- 2026-08-01
- Primary completion
- 2026-09-30
- Sex
- All
- Age range
- from 18 Years to 85 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age between 18 and 85 years * Receiving hemodialysis treatment for at least 3 months * No diagnosis of malignant respiratory disease (e.g., bronchial or lung cancer) * No pathological condition affecting consciousness or focus (e.g., dialysis dementia or uremic encephalopathy) * Native Turkish speaker Exclusion Criteria: * Advanced reading comprehension problems * Advanced hearing impairment * Presence of sleep apnea * Known psychiatric illness.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07700693